Researchers are exploring various approaches to immunotherapy for pancreatic cancer, including the use of engineered cells and targeted delivery strategies. Studies are investigating different methods to overcome challenges in treating the disease, such as drug resistance and tumor recurrence. The field of pancreatic cancer immunotherapy appears to be actively advancing, with multiple areas of focus and potential avenues for clinical application.